Today's Hours: 8:00am - 10:00pm
Lane Medical Library

Search

Filter Results

Did You Mean:

Search Results

Sort by
relevance
  • Book
    Hitesh Verma, Alok Thakar, editors.
    Summary: This book serves as a practical guide for the otorhinolaryngologists to better understand the diseases of the sinonasal region, diagnosis, and management. The detailed knowledge of the complex anatomy of the sinonasal region is the key to surgical success. The text aims to help budding and practicing rhinologists to get an essence abreast of the current scientific advancement by engaging rhinologists with excellent awareness and knowledge as contributors. The book expands its span afar the usual by including topics on complications of endoscopic surgeries, empty sinus syndrome, packing material, open transcranial approach, biofilm, instruments, cavity management, and improved quality of life, etc. The purpose of microbiology, interventional radiology, pathology and nuclear medicine in the diagnosis and management of sinonasal diseases is contributed by authors from allied specialties. This book will be a useful resource for medical students, postgraduates in ENT, practicing rhinologists and general physicians in treating sinonasal diseases. .

    Contents:
    Endoscopic anatomy and surgery
    Rhinoplasty anatomy and procedures
    Nasal physiology and sinusitis
    Granulomatous disease and faciomaxillary trauma
    Diagnostic method and instrumentation in rhinology
    Tumours of nose and paranasal sinuses
    Extended procedures
    Prevention and management of complications
    Septum, adenoid and epistaxis
    Radiotherapy, chemotherapy and quality of life.
    Digital Access Springer 2021
  • Article
    Issell BF, Valdivieso M, Hersh EM, Richman S, Gutterman JU, Bodey GP.
    Cancer Treat Rep. 1978 Jul;62(7):1059-63.
    In a prospective randomized trial, sc Corynebacterium parvum (C. parvum) immunotherapy did not significantly affect the responses and survival of 49 non-oat cell lung cancer patients receiving isophosphamide and adriamycin chemotherapy. Remissions (tumor regression greater than 50%) were seen in five of 23 patients receiving an intensive C. parvum schedule and in three of 26 patients receiving a nonintensive C. parvum schedule (22% versus 12%). Median survival was 20 weeks for patients given intensive C. parvum and 23 weeks for patients given nonintensive C. parvum. This study did demonstrate the importance of pretherapy immunocompetence, performance status, and weight loss as predictors for survival. Weight loss was the most significant prognostic factor. Performance status was closely associated with weight loss but skin reactivity to dermatophytin predicted independently and was the second most important prognostic characteristic.
    Digital Access Access Options